Bronchial carcinoid- An unusual cause of hemoptysis in a young woman.
Abstract
Bronchial neuroendocrine tumors(NET) are slow growing rare pulmonary tumors arising from neuroendocrine cells. Bronchial NETs account for 1 to 2 percent of all lung malignancies in adults. These tumors are usually sporadic, although 10 percent have features suggesting hereditary origin either multiplicity or association with MEN I. Well differentiated NETs are also known as carcinoid tumors which includes low and intermediate grade groups. Poorly differentiated NETs are high grade tumors which include small cell carcinoma and large cell neuroendocrine carcinoma. Here we present a 32 year old female patient with no comorbid illness who came with complaints of hemoptysis. Subsequent evaluation revealed intrabronchial carcinoid as the cause of hemoptysis. Thus in young patients with no known risk factors, presenting with hemoptysis, bronchial carcinoid should be considered in the differential diagnosis
Full Text:
PDFReferences
Modlin IM, lye KD, Kidd M. A Five Decade Analysis of 13,715 Carcinoid tumors. Cancer. 2003; 97(4):934-959.
Alexandria T Phan, Kjell Oberg, Junsung Choi et al. NANETS Consensus Guidelines for the Diagnosis and Management of Neuroendocrine Tumors. Pancreas. 2010; 39: 784-798.
C. Bhatia and Ellis S. Unusual Lung Tumors: An Illustrated Review of CT Features Suggestive of the Diagnosis. Cancer imaging.2006; 6(1):72-82.
Fischer S, Kruger M, Mcrae K, Merchant N, Tsao MS and Keshavjee S. Giant Bronchial Carcinoid Tumors: a Multidisciplinary Approach. Ann Thorac Surg.2001;71(1):386-393.
Fink G, Krelbaum T, Yellin A, Bendayan D, Saute M, Glazer M et al. Pulmonary Carcinoid Presentation,Diagnosis and Outcome in 142 cases in Israel and Review of 640 cases from the Literature. Chest.2011;119(6):1647-1651.6. William Travis, Dorothy Giroux et al., The IASLC Lung Cancer Staging Project: Proposals for the inclusion of broncho-pulmonary carcinoid tumors in the forthcoming (seventh) edition of the TNM Classification for Lung Cancer. Journal of Thoracic Oncolgy, Lippincott, Williams & Wilkins, 2008, 3
(11), pp.1213-23. 7.Chong S, Lee KS, Chung MJ, Han J, Kwon OJ, Kim TS. Neuroendocrine Tumors of the Lung: Clinical, Pathological and Imaging Findings. Radiographics. 2006;26(1):41-57.
Campana D, Nori F, Piscitelli L, Morselli-Labate AM, Pezzilli R, Corinaldesi R, et al. Chromogranin A: Is it a useful marker of Neuroendocrine Tumors? J Clin Oncol. 2007;25(15):1967–73.
Refbacks
- There are currently no refbacks.
This work is licensed under a Creative Commons Attribution-NoDerivatives 4.0 International License.
An initiative of The Tamil Nadu Dr M.G.R. Medical University